Efficacy and Safety of Recombinant Human Growth Hormone on Height Velocity in Subjects With Idiopathic Short Stature
Clinical trial NCT01778023 · COMPLETED
Trial details
- NCT number
- NCT01778023
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-17
- Primary completion
- 2014-12-17
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.